Treatment for Drug-Induced Psychosis
For acute drug-induced psychosis, use a benzodiazepine (lorazepam or midazolam) or a conventional antipsychotic (haloperidol or droperidol) as first-line monotherapy, with antipsychotics reserved for short-term use and gradual discontinuation once the patient is stable 1, 2.
Initial Management Approach
The cornerstone of treatment is discontinuation of the offending substance combined with supportive care 2, 3. Rule out medical emergencies first, then address acute intoxication or withdrawal states before initiating pharmacologic treatment.
Acute Pharmacologic Treatment
For the acutely agitated patient with drug-induced psychosis:
- Benzodiazepines (lorazepam or midazolam) OR conventional antipsychotics (haloperidol or droperidol) are equally effective as monotherapy 1
- If rapid sedation is specifically required, droperidol is superior to haloperidol 1
- For cooperative patients who can take oral medications: combine oral lorazepam with oral risperidone 1
- For severe agitation requiring parenteral treatment: combining a benzodiazepine with haloperidol may produce faster sedation than monotherapy 1
Substance-Specific Considerations
Cannabis-induced psychosis: Risperidone and haloperidol show comparable efficacy in randomized trials 4
Methamphetamine-induced psychosis: Quetiapine and haloperidol demonstrate similar effectiveness. Aripiprazole, olanzapine, and risperidone are also effective for controlling both positive and negative symptoms 4, 5
Cocaine and hallucinogen-induced psychosis: No controlled studies exist, but the general antipsychotic approach applies 4
Duration and Discontinuation
Critical distinction: Drug-induced psychosis is expected to resolve within 30 days of sobriety 2. This differentiates management from primary psychotic disorders:
- Use antipsychotics for short-term treatment only 2
- Gradually discontinue antipsychotics once the patient is stable and substance-free 2
- Do NOT continue maintenance antipsychotic treatment as you would for schizophrenia unless conversion to a primary psychotic disorder occurs
Monitoring for Conversion
High-risk warning: 25-50% of drug-induced psychoses progress to schizophrenia or bipolar disorder within 5 years 2, 6. Risk factors include:
- Cannabis use (highest risk)
- Early-onset substance abuse
- Episodes of self-harm during the psychotic episode
- Younger age at presentation
Monitor these patients longitudinally and reassess diagnosis if symptoms persist beyond 30 days of sobriety 2.
Common Pitfalls
Avoid these errors:
Do not treat drug-induced psychosis like schizophrenia with long-term maintenance antipsychotics—this is a self-limited condition requiring short-term treatment only 2
Do not use anticholinergics routinely for preventing extrapyramidal side effects; reserve them only for acute or severe symptoms when dose reduction or switching has failed 7
Do not assume psychosis will resolve without treatment—some patients develop persistent psychotic symptoms, emotional disturbance, and cognitive impairment without intervention 5
Do not overlook medical causes—steroids, antiepileptics, antimalarials, and antiretrovirals can all induce psychosis and require different management (drug cessation) 3
Relapse Prevention
Once acute symptoms resolve:
- Implement both medication-based and non-medication-based relapse prevention strategies 2
- Address underlying substance use disorder with appropriate addiction treatment
- Provide psychoeducation about the risk of conversion to primary psychotic disorder
- Monitor for suicidal behavior, which strongly predicts conversion to schizophrenia or bipolar disorder 2
The evidence base remains limited, particularly for cocaine and hallucinogen-induced psychoses, but the general principle holds: treat acutely with antipsychotics or benzodiazepines, discontinue gradually when stable, and maintain vigilance for conversion to primary psychotic illness 4, 2.